Bookmark

Add to MyYahoo RSS

Albany Molecular Research News

News on Albany Molecular Research (Ticker: AMRI) continually updated from thousands of sources around the net.

Tuesday Jul 8 | Customer Interaction Solutions

Analysts Review Releases Notes on Alere, AMRI, Anika Therapeutics,...

On July 4, Analysts Review released its analysts' notes regarding Alere, Albany Molecular Research, Anika Therapeutics, Nektar Therapeutics and Sangamo Biosciences.

Comment?

Related Topix: Biotech, Medicine, Anika Therapeutics, Healthcare Industry, Sangamo Biosciences, Startups, Nektar Therapeutics, Bind Biosciences

Mon Jul 07, 2014

Investor's Business Daily

Albany Molecular's Oso Buy Seen Boosting Earnings

In a report issued Monday morning, Sterne Agee analyst Greg Bolan said he is "officially incorporating our estimates for accretion" into Albany's earnings for this year and next year.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Jul 01, 2014

Freshnews

AMRI Completes Acquisition of Oso Biopharmaceuticals Manufacturing

AMRI today announced that it has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of Altaris Capital Partners, LLC. The transaction is consistent with AMRI's strategy to be the preeminent supplier of custom and complex drug product development and manufacturing services to the pharmaceutical industry.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, EPS, Pharmacology

AmericanBankingNews.com

Albany Molecular Research Reaches New 12-Month High at $21.14

Albany Molecular Research hit a new 52-week high on Tuesday , American Banking News.com reports.

Comment?

Related Topix: Biotech, Medicine, AMR Research, Healthcare Industry, Advertising, Stanley

Mon Jun 23, 2014

BioSpace

Albany Molecular Research, Inc. (AMRI) Announces Early Termination Of ...

The early termination of the HSR waiting period satisfies one of the conditions to the proposed acquisition.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Large Scale Biology, Pharmacology

Thu Jun 19, 2014

Business Journal

Ciminelli seeks added tax breaks for AMRI at Conventus

The addition of Albany Molecular Research Inc. as an anchor tenant in the Conventus project is prompting the developers to seek a separate incentive package for the company's local expansion plans.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Home, Mortgage, Personal Finance

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••